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Introduction
Kawasaki disease (KD) is an acute febrile vasculitis and
the most common acquired heart disease in children
worldwide, and is associated with a higher incidence
in Asian countries. Dr Tomisaku Kawasaki originally
described KD in a Japanese-language medical journal
in 1967.1 A prompt diagnosis is critically important,
because the major complications (coronary artery
abnormalities) can be reduced from 20–25% to 3–5%
by the administration of intravenous immunoglobulin
(IVIG) within 10 days of the onset of illness.2 In addi-
tion, KD was recently reported as a potential risk factor
for adult ischemic heart disease and sudden death in
early adulthood.3
A previous study revealed that 30% of the patients
hospitalized for treatment of KD were diagnosed after
day 10 of the illness.4 In spite of the relatively high
occurrence of delayed diagnosis of KD, information on
the possible risk factors and clinical manifestations is
still limited. Identifying the specific characteristics of 
a delayed diagnosis of KD might be helpful for avoiding
a delayed diagnosis, promoting an earlier recognition of
KD and reducing the rate of coronary artery complica-
tions. The purpose of this study was to investigate the
risk factors and clinical manifestations in children with
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a delayed diagnosis of KD. We hypothesized that the
patients with a delayed diagnosis of KD might have a
younger age, more delayed first physician visit, receive
more antibiotics for other diagnoses, or an atypical
clinical presentation.
Methods
The medical records of the patients diagnosed with
KD between January 1996 and December 2005 in
our institution were retrospectively reviewed. All charts
were identified by the discharge diagnosis (Inter-
national Classification of Disease, Ninth Revision
[ICD-9] code 446.1) and reviewed by 2 investigators
to ensure that patients met the clinical criteria for KD.
Any medical charts with incomplete records were
excluded. We collected detailed information from the
medical records including demographic characteristics,
echocardiographic results, drugs prescribed, laboratory
data, clinical symptoms (day of onset and duration),
and number of days from the onset of symptoms to
diagnosis. Coronary artery abnormalities were docu-
mented as present if they were seen on any echocar-
diogram on either the day of presentation or during
follow-up.
Definitions
The diagnostic criteria of KD by the American Heart
Association was established by an existence of a high
fever for more than 5 days and 4 or 5 of the following
5 criteria: (1) bilateral bulbar conjunctival infection,
generally nonpurulent; (2) changes in the mucosa 
of the oropharynx, including an infected pharynx,
infected and/or dry fissured lips and a strawberry
tongue; (3) changes in the peripheral extremities, such
as edema and/or erythema of the hands or feet in the
acute phase, or periungual desquamation in the sub-
acute phase; (4) rash, primarily truncal, polymorphous
but nonvesicular; and (5) cervical lymphadenopathy,
≥ 1.5 cm, usually in the unilateral cervical region.5
The number of days of specific signs was defined
as the interval in days from the onset of signs to the
resolution of signs. Patients with an early diagnosis
were defined as those having diagnosis of KD made
within or by 10 days after the onset of the fever.
Patients with a delayed diagnosis were defined as hav-
ing diagnosis of KD made more than 10 days after 
the onset of the fever. The criteria of the coronary
artery abnormalities detected by echocardiography
included: (1) a diameter of the internal lumen of
more than 3 mm; (2) an internal diameter of a segment
1.5 times greater than that of an adjacent segment
(saccular or fusiform aneurysm); and (3) irregular
surface and/or perivascular brightness of the coronary
arterial wall.6
Statistical analysis
Pearson’s χ2 test and Student’s t test were used 
for statistical analyses and comparisons between the 
2 groups. The collected data that were not normally
distributed were compared by using the Mann–
Whitney rank sum test. Pearson correlation coeffi-
cients were calculated to establish any correlations
between the demographic data, clinical manifestations
and laboratory findings in the patients. Statistical sig-
nificance was defined as a p value < 0.05.
Results
Patient characteristics
During a 10-year period, 78 patients with detailed
medical records and diagnosed with KD (ICD-9 code
446.1) were enrolled in this study. Fifty-seven patients
with unsure recall of clinical history, incomplete med-
ical records or laboratory data were excluded from
the study. Sixty-four (82.1%) of the 78 patients were
categorized into the early-diagnosis group (EDG,
Group I) (mean age, 25 ± 24 months; male/female
ratio, 40/24), and 14 (17.9%) children were cate-
gorized into the delayed-diagnosis group (DDG,
Group II) (mean age, 23 ± 19 months; male/female
ratio, 9/5). There were no significant differences in
the patient characteristics, including age and gender,
between the 2 groups.
Clinical characteristics and laboratory 
features
The duration of symptoms and first contact with 
a medical provider are shown in Table 1. There was a
trend for the total number of days of a fever, skin
rash, mucosa changes and extremity changes to be
longer in Group II patients than in Group I patients,
but only the difference in duration of fever was statis-
tically significant. Between the 2 groups, the number
of antibiotics prescribed and day of the first medical
contact were similar, and there were no significant
differences between the 2 groups.
With regard to laboratory findings, the white blood
cell count (WBC) on admission was significantly higher
in DDG patients than in EGD patients (23.5 × 103 vs.
14.9 × 103/µL; p = 0.043) (Table 2). The levels of
immunoglobulin G were also significantly higher in
Group II patients (766 ± 431 vs. 1,377 ± 711 mg/dL;
p = 0.001).
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Physician visit and the initial diagnosis
The majority of the patients in each group (EDG,
73%; DDG, 92%) had sought their first medical atten-
tion during the first 3 days of their illness. Overall,
76.9% of the patients with KD first presented to a
physician between days 1 and 3 of their illness. No
significant difference between these 2 groups for the
mean day of their first physician visit was noted. At
the first visit, many different diagnoses were given
and only 14 of 78 patients (17.9%) had a diagnosis of
KD initially. The initial diagnoses of all the patients
are listed in Table 3. An upper respiratory tract infec-
tion, acute pharyngitis and lymphadenitis were the 3
most common initial diagnoses in both groups.
The onset of the physical signs of KD
A trend of developing signs of KD tightly clustered
within 5 days of the illness was demonstrated in the
EDG group. In contrast, DDG group patients had the
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Table 1. The potential risk of a delayed diagnosis in patients with Kawasaki disease*
Variables Group I (n = 64) Group II (n = 14) p
Days of fever 7.1 ± 1.6 (6.7–7.5) 14.0 ± 3.2 (12.1–15.9) < 0.010†
Days of skin rash 4.4 ± 1.6 (4.0–4.8) 6.5 ± 5.2 (3.4–9.7) 0.334
Days of conjunctivitis 6.2 ± 1.5 (3.8–4.6) 6.0 ± 4.3 (3.4–8.6) 0.269
Days of mucosa changes 4.3 ± 1.5 (3.9–4.7) 5.8 ± 3.3 (3.6–7.9) 0.221
Days of extremity changes 2.7 ± 1.7 (2.2–3.2) 4.7 ± 3.2 (2.2–7.1) 0.072
Presence of lymphadenopathy 46.9% 57.1% 0.688
Number of antibiotic prescriptions 1.6 ± 0.7 (1.4–1.9) 1.6 ± 0.5 (1.1–2.1) 0.960
First contact with a medical provider, day of illness 2.6 ± 1.4 (2.3–3.0) 2.6 ± 1.0 (2.0–3.2) 0.934
*Data are presented as mean ± standard deviation (95% confidence interval) or %; †statistically significant at p < 0.05. Group I = early-diagnosis group; 
Group II = delayed-diagnosis group.
Table 2. Laboratory findings of patients with an early/delayed diagnosis of Kawasaki disease*
Characteristic Group I (n = 64) Group II (n = 14) p
WBC (× 1000/µL) 14.9 ± 4.8 (13.7–16.1) 23.5 ± 19.8 (12.0–35.0) 0.043†
Platelets (× 1000/µL) 357 ± 163 (317–398) 407 ± 205 (288–525) 0.325
CRP (mg/dL) 11.0 ± 6.8 (9.4–12.8) 9.3 ± 8.7 (4.2–14.3) 0.424
IgG (mg/dL) 766 ± 431 (645–887) 1,377 ± 711 (947–1,806) 0.001†
IgA (mg/dL) 83 ± 53 (68–98) 109 ± 66 (69–149) 0.114
IgM (mg/dL) 130 ± 48 (116–143) 169 ± 86 (117–222) 0.166
Albumin (g/dL) 3.8 ± 0.5 (3.7–4.0) 3.6 ± 0.4 (3.2–4.0) 0.231
HDL (mg/dL) 24 ± 10 (21–27) 25 ± 10 (18–32) 0.736
LDL (mg/dL) 77 ± 25 (70–84) 83 ± 31 (61–105) 1.000
Triglyceride (mg/dL) 142 ± 75 (120–163) 126 ± 44 (95–158) 0.675
Cholesterol (mg/dL) 129 ± 30 (121–137) 135 ± 30 (113–157) 0.589
AST (U/L) 52 ± 41 (41–62) 106 ± 196 (13–225) 0.774
ALT (U/L) 74 ± 84 (53–95) 112 ± 173 (7–216) 0.317
*Data are presented as mean ± standard deviation (95% confidence interval); †statistically significant at p < 0.05. Group I = early-diagnosis group; Group II =
delayed-diagnosis group; WBC = white blood cell count; CRP = C-reactive protein; IgG/A/M = immunoglobulin G/A/M; HDL = high-density lipoprotein; LDL =
low-density lipoprotein; AST = aspartate aminotransferase; ALT = alanine aminotransferase.
Table 3. Diagnoses of the patients with Kawasaki disease at the
first medical visit*
Diagnosis Group I Group II
Upper respiratory infection 17 (26.6) 9 (64.3)
Kawasaki disease 14 (21.9)
Acute pharyngitis 7 (10.9) 2 (14.3)
Lymphadenitis 7 (10.9) 2 (14.3)
Urinary tract infection 4 (6.3)
Scarlet fever 3 (4.7)
Acute gastroenteritis 3 (4.7)
Acute tonsillitis 2 (3.1) 1 (7.1)
Acute otitis media 2 (3.1)
Bronchopneumonia 2 (3.1)
Acute bronchiolitis 1 (1.6)
Enterovirus infection 1 (1.6)
Roseola infantum 1 (1.6)
Total 64 (100.0) 14 (100.0)
*Data are presented as n (%). Group I = early-diagnosis group; Group II =
delayed-diagnosis group.
onset of the signs dispersed over 10 days. The onset
of additional signs in both groups is compared in
Table 4. There was no statistical difference in the first
medical contact between the 2 groups (2.6 ± 0.7 vs.
2.6 ± 1.0 days; p = 0.934).
Coronary artery abnormalities
In this study, a total of 15 patients with KD (19.2%)
had coronary artery abnormalities recognized by echo-
cardiography at either the initial presentation or during
follow-up despite any IVIG therapy (Table 5). Group II
patients had a statistically significant higher incidence
of coronary artery abnormalities (42.9% vs. 14.1%;
p = 0.036). On the other hand, higher incidence of
coronary artery abnormalities in patients whose age
was less than 1 year was found (29.0% vs. 12.7%;
p = 0.043).
Discussion
The incidence of KD varies among different coun-
tries, and Asian countries allegedly have a higher inci-
dence than Western countries. In Taiwan, the annual
KD incidence is reported to be around 66/100,000
in children < 5 years old, and it is the second highest
in the world.7 Therefore, KD is familiar to most pedi-
atricians in Taiwan. Therefore, it should be an early
consideration as a differential diagnosis in febrile chil-
dren in order to decrease the rate of delayed diagno-
sis. A previous study demonstrated that 30% of KD
patients were diagnosed after 10 days of the illness.4
In the present study, 14 of 78 children (17.9%) were
diagnosed after day 10 of the illness, a relatively lower
incidence when compared with the previous study.4
We hypothesized that delayed diagnosis of KD
might result from patients having younger age, more
delayed first physician visit, patients having received
more antibiotics for other diagnoses, or an atypical
clinical presentation. After analyzing the medical his-
tories and clinical courses of the EDG and DDG
group patients, most of these hypotheses were refuted
by the study results. Being a patient with younger age
was not a significant factor for a delayed diagnosis,
and most patients had their first medical visit within 3
days of the onset of illness in both groups. Therefore,
most of the patients’ parents or caregivers were very
vigilant about the fever attacks, and made an early
medical visit. Unfortunately, even with a high percent-
age of early visits on days 1–3 of the illness (76.9%),
only 14 patients (17.9%) were diagnosed with KD.
Most of the initial diagnoses indicated some signs and
symptoms associated with KD. For example, upper
respiratory tract infections reflected a mild cough,
rhinorrhea and fever. The diagnosis of lymphadenitis,
urinary tract infection and scarlet fever reflected lym-
phadenopathy, pyuria and polymorphous exanthema,
respectively. The inaccurate initial diagnoses may have
been due to having received an inappropriate treat-
ment. In addition, there have been multiple descrip-
tions in previous literature of patients with KD, but
they had an initial diagnosis of cervical adenitis,
meningitis, pneumonia, appendicitis, pyelonephritis
or retropharyngeal abscess.8–13 It was interesting to
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Table 5. Coronary artery abnormalities in patients with Kawasaki disease according to age*
Age (mo) Group I (n = 64) Group II (n = 14) Total
< 12 (n = 31) 5/64 (7.8) 4/14 (28.6) 9/31 (29.0)
≥ 12 (n = 47) 4/64 (6.2) 2/14 (14.3) 6/47 (12.7)
Total 9/64 (14.1) 6/14 (42.9) p = 0.043†
p = 0.036†
*Data are presented as n (%); †statistically significant at p < 0.05.
Table 4. Onset of the symptoms and signs of Kawasaki disease*
Group I (n = 64) Group II (n = 14) p
Mucosa changes on the day of illness 3.8 ± 1.5 (3.4–4.2) 8.2 ± 3.7 (5.8–10.6) < 0.001†
Conjunctivitis on the day of illness 3.9 ± 1.3 (3.6–4.3) 7.6 ± 3.6 (5.4–9.8) < 0.001†
Skin rash on the day of illness 3.5 ± 1.6 (3.1–3.9) 6.2 ± 3.9 (3.7–8.5) 0.026†
Lymphadenopathy on the day of illness 3.1 ± 1.7 (2.4–3.7) 6.1 ± 3.7 (2.9–9.2) 0.032†
Extremity changes on the day of illness 4.9 ± 1.4 (4.5–5.3) 9.5 ± 3.9 (6.5–12.5) < 0.001†
*Data are presented as mean ± standard deviation (95% confidence interval); †statistically significant at p < 0.05.
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note that in both the EDG and DDG groups, the
medical providers usually focused only on some signs
or symptoms associated with KD.
We analyzed the clinical manifestations and labora-
tory data, but no significant difference between the
groups was demonstrated in this study (Tables 1 and 2).
However, prolonged fever and higher WBC were
demonstrated in the DDG patients and may have
resulted from the prolonged course of a systemic
inflammation. The higher level of serum IgG in the
DDG patients has not been mentioned in other reports,
and further study to explain this is necessary. Our
results differed from the study in Denver in which
fever, rash or platelet count were strong predictors of
KD in DDG children.14
We considered that with the close clustering of
symptoms in the EDG patients, the patients had
returned earlier or more frequently for medical atten-
tion, which helped the doctors recognize a diagnosis
of KD. On the other hand, not only the statistical differ-
ence of a delayed onset of signs (mucosa change, skin
rash, conjunctivitis) in the DDG patients, but also this
timeline model, suggested that the dispersion of the
symptoms may have been a factor in late diagnosis.
Due to most patients having had the first medical visit
after a fever attack, but without appearance of any other
KD signs, it is important to advise that patients should
return if there is any persistent fever or appearance of
any other signs.
There were similar observations in other previous
studies.15–17 Children < 1 year old with KD are signifi-
cantly more likely to develop coronary artery abnor-
malities than older children. In both groups, the
percentage of males with KD was higher than the per-
centage of females, and that was compatible with the
results of a general report. A delayed diagnosis was
harmful in patients because there was a higher possi-
bility of developing coronary abnormalities in DDG
than in EDG patients (42.9% vs. 14.1%; p = 0.036). It
is reasonable to hypothesize that prolonged and
untreated inflammation may put DDG patients at
higher risk for coronary artery involvement.
This study does have several weaknesses and biases
that we should illustrate. Due to having only a small
group of DDG patients, there may not have been a
large enough group to demonstrate any statistical sig-
nificance for the clinical comparison. We underesti-
mated the methods of use of IVIG (2 g/kg/dose × 1
dose or 400 mg/kg/day × 5 days), duration of aspirin
prescribed and primary care provider’s specialty in
this study. These above weaknesses may have influ-
enced and masked the results of the real observations
in this study.
In conclusion, our study showed that 17.9% of the
children with KD were diagnosed after the 10th day of
illness and were associated with higher WBC and IgG
levels. DDG patients exhibited a more dispersed and
late onset of the clinical features of KD as compared
with EDG patients, in whom symptoms and signs
appeared in clusters. A higher percentage of DDG
patients and patients younger than 1 year developed
coronary artery abnormalities. It is necessary to
develop a diagnostic test for KD and to provide more
education to health care providers for early recogni-
tion of KD.
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